000 | 01819 a2200469 4500 | ||
---|---|---|---|
005 | 20250513202214.0 | ||
264 | 0 | _c20000309 | |
008 | 200003s 0 0 eng d | ||
022 | _a0022-1767 | ||
024 | 7 |
_a10.4049/jimmunol.164.4.1734 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMorris, S C | |
245 | 0 | 0 |
_aIL-4 suppression of in vivo T cell activation and antibody production. _h[electronic resource] |
260 |
_bJournal of immunology (Baltimore, Md. : 1950) _cFeb 2000 |
||
300 |
_a1734-40 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntibodies, Monoclonal _xadministration & dosage |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGoats |
650 | 0 | 4 |
_aImmunoglobulin D _xadministration & dosage |
650 | 0 | 4 |
_aImmunoglobulin E _xbiosynthesis |
650 | 0 | 4 |
_aImmunoglobulin G _xbiosynthesis |
650 | 0 | 4 |
_aImmunosuppressive Agents _xadministration & dosage |
650 | 0 | 4 | _aInjections, Intravenous |
650 | 0 | 4 |
_aInterferon-gamma _ximmunology |
650 | 0 | 4 |
_aInterleukin-1 _xantagonists & inhibitors |
650 | 0 | 4 |
_aInterleukin-2 _xantagonists & inhibitors |
650 | 0 | 4 |
_aInterleukin-4 _xadministration & dosage |
650 | 0 | 4 |
_aLymphocyte Activation _ximmunology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred BALB C |
650 | 0 | 4 | _aMice, Inbred MRL lpr |
650 | 0 | 4 |
_aReceptors, Interleukin-2 _xantagonists & inhibitors |
650 | 0 | 4 |
_aT-Lymphocytes _ximmunology |
650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xphysiology |
700 | 1 | _aGause, W C | |
700 | 1 | _aFinkelman, F D | |
773 | 0 |
_tJournal of immunology (Baltimore, Md. : 1950) _gvol. 164 _gno. 4 _gp. 1734-40 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.4049/jimmunol.164.4.1734 _zAvailable from publisher's website |
999 |
_c10612585 _d10612585 |